RheinBio: Notice on holding the second extraordinary shareholders\' meeting in 2024
RheinBio: Comparative table of amendments to the articles of association (November 2024)
Rhine Biotech: Announcement on capital increase for its wholly-owned subsidiary Shanghai Biyan
Rheinbio: Announcement on the official commissioning of the company\'s synthetic biology workshop project
Rhine Biotech: Legal Opinions of Beijing Deheng Law Firm on the 2024 First Extraordinary General Meeting of Shareholders of Guilin Rhine Biotechnology Co., Ltd.
RheinBio: Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders
RheinBio: An indicative announcement on the holding of the 2024 First Extraordinary General Meeting of Shareholders
RheinBio: Emergency Response System for Emergency Situations (August 2024)
RheinBio: 2024 semi-annual financial report
RheinBio: Comparative table of amendments to the articles of association (August 2024)
Rheinland Biotech: Semi-annual summary of non-operating capital consumption and other related capital transactions
RheinBio: Notice on convening the first Extraordinary General Meeting of Shareholders in 2024
Guilin Layn Natural Ingredients Corp.: Announcement regarding the resignation of the company's director.
Guilin Layn Natural Ingredients Corp.: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Guilin Layn Natural Ingredients Corp.: Legal Opinions of Beijing Deheng Law Firm on the 2023 Annual General Meeting of Shareholders of Guilin Rhine Biotechnology Co., Ltd.
Guilin Layn Natural Ingredients Corp.: Prompt Announcement on Convening the 2023 Annual General Meeting of Shareholders
RheinBio: Announcement on the freezing of some funds in the company's bank account
RheinBio: Special instructions on securities investment
RheinBio: Comparative table of amendments to the articles of association (April 2024)
RheinBio: Internal Control Self-Assessment Report
No Data
No Data